SlideShare a Scribd company logo
1 of 3
Download to read offline
CURRICULUM VITAE
STANLEY B. KAHLER, B.A.
Clinical Trials Management Resources, LLC
3585 Deer Valley Dr, Castle Rock, CO 80104
Phone 720-270-2309 email: sbkahler66@gmail.com
Education
Bachelor of Arts Union College
Chemistry Lincoln, NE
1989
Experience
Clinical Trials Management Resources, LLC 2009-present
Clinical Research Coordinator
Cedarburg Hauser Pharmaceuticals 2011-2012
Denver, CO
Analytical Chemist
Anlaytical Services
Array Biopharma, Inc. 2006-2009
Longmont, CO
Research Associate
Analytical Research and Development
Mayne Pharma 2005-2006
(formerly Napro Biotherapeutics, now Hospira)
Boulder, CO
Analytical Chemist
Technical Services Group
Tapestry Pharmaceuticals 2002-2005
(formerly Napro Biotherapeutics)
Boulder, CO
Chemist
Analytical Development/Chemistry Development
Napro Biotherapeutics 2000-2002
Boulder, CO
Chemist
Analytical Development/Chemistry Development
Rosemont Pharmaceuticals 1993-2000
(now Upsher Smith)
Analytical Chemist
Harris Laboratories 1990-1992
Lincoln, NE
Analytical Chemist
Stanley B. Kahler, B.A.
Page 2 of 3
Union College, Lincoln, NE 1985-1989
Full time student
Investigative Trials
Clinical Research Coordinator. A Phase 3, Multi-center, Randomized, Double-Blind, Controlled
Study of the Long-Term Analgesic Efficacy and Safety of Tanezumab Alone or in
Combination with Non-Steroidal Anti-inflammatory Drugs (NSAIDS ) versus NSAIDS
Alone in Patients with Osteoarthritis of the Knee or Hip. Pfizer Inc. Jan 2009-May 2009.
Clinical Research Coordinator. A 26 Week, Double-Blind, Randomized, Placebo-Controlled Study
of the Efficacy and Safety of Single Intra-Articular Injection 1.2% Sodium Hyaluronate for
Treatment of Painful Osteoarthritis of the Knee, with Optional 26-Week Open-Label Safety
Extension. Ferring International Pharmascience Center, U.S., Inc. August 2009-April 2011.
Clinical Research Coordinator. Long-term Allopurinol Safety Study Evaluating Outcomes in Gout
Patients (LASSO). Ardea Biosciences, Inc. November 2011-May 2013.
Clinical Research Coordinator. A Phase 3 Randomized, Double-Blind, Multicenter, Placebo-
Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and
Allopurinol Compared to Allopurinol Alone in Subjects with Gout who have had an
Inadequate Hypouricemic Response to Standard of Care Allopurinol (CLEAR 1). Ardea
Biosciences, Inc. March 2012-September 2014.
Clinical Research Coordinator. A Phase 3 Randomized, Double-Blind, Multicenter, Placebo-
Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to
Placebo in Subjects with Gout who have had an Intolerance or Contraindication to a
Xanthine Oxidase Inhibitor (LIGHT). Ardea Biosciences, Inc. March 2012- November 2013
Clinical Research Coordinator. A Phase 3 Randomized, Double-Blind, Multicenter, Placebo-
Controlled Combination Study to Evaluate the Efficacy and Safety of Lesinurad and
Febuxostat Compared to Febuxostat Alone at Lowering Serum Uric Acid and Resolving
Tophi in Subjects with Tophaceous Gout (CRYSTAL). Ardea Biosciences, Inc. March
2012-July 2014.
Clinical Research Coordinator. A Long-Term Open-Label Study for Subjects Completing
a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects with Gout.
LIGHT Extension Study. Ardea Biosciences, Inc. November 2012-July 2014.
Clinical Research Coordinator. A Long-Term Extension Study of Lesinurad in Combination with
Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and
Allopurinol. CLEAR Extension Study. Ardea Biosciences, Inc. August 2013-present.
Clinical Research Coordinator. A Long-Term Extension Study of Lesinurad in Combination with
Febuxostat for Subjects with Gout Completing an Efficacy and Safety Study of Lesinurad
and Febuxostat. CRYSTAL Extension Study. Ardea Biosciences, Inc. May 2013-present.
Stanley B. Kahler, B.A.
Page 3 of 3
Clinical Research Coordinator. A Multi-Center, Randomized, Double-Blind, Phosphate Buffered
Saline-Controlled Study to Evaluate Effectiveness and Safety of a Single Intra-Articular
Injection of Gel-One® for the Treatment of Osteoarthritis of the Knee with Open-Label
Safety Extension. August 2013 - April 2016
Clinical Research Coordinator. A Study to Determine the Presence and Volume of Monosodium
Urate Crystals as Assessed by Dual-Energy Computed Tomography in Gout Patients
Treated with Allopurinol. May 2015 – March 2016

More Related Content

What's hot

Drug discovery process powerpoint presentation slides ppt templates
Drug discovery process powerpoint presentation slides ppt templatesDrug discovery process powerpoint presentation slides ppt templates
Drug discovery process powerpoint presentation slides ppt templatesSlideTeam.net
 
Drug design
Drug designDrug design
Drug designDrARIFA1
 
Drug Discovery Process by Kashikant Yadav
Drug Discovery Process by Kashikant YadavDrug Discovery Process by Kashikant Yadav
Drug Discovery Process by Kashikant YadavKashikant Yadav
 
Drug design, discovery and development
Drug design, discovery and developmentDrug design, discovery and development
Drug design, discovery and developmentFarzana Sultana
 
Drug discovery, Design & development basics
Drug discovery, Design & development basicsDrug discovery, Design & development basics
Drug discovery, Design & development basicsResearchsio
 
Drug Discovery Presentation
Drug Discovery PresentationDrug Discovery Presentation
Drug Discovery PresentationLucyhague
 
Lead development and drug discovery
Lead development and drug discoveryLead development and drug discovery
Lead development and drug discoveryApuMarma
 
Basics of Drug Discovery and Development
Basics of Drug Discovery and DevelopmentBasics of Drug Discovery and Development
Basics of Drug Discovery and DevelopmentJhony Sheik
 
Computer aided drug design(CADD)
Computer aided drug design(CADD)Computer aided drug design(CADD)
Computer aided drug design(CADD)Sameh Abdel-ghany
 
Development and sharing of ADME/Tox and Drug Discovery Machine learning models
Development and sharing of ADME/Tox and Drug Discovery Machine learning modelsDevelopment and sharing of ADME/Tox and Drug Discovery Machine learning models
Development and sharing of ADME/Tox and Drug Discovery Machine learning modelsSean Ekins
 
LEAD IDENTIFICATION BY SUHAS PATIL (S.K.)
LEAD IDENTIFICATION BY SUHAS PATIL (S.K.)LEAD IDENTIFICATION BY SUHAS PATIL (S.K.)
LEAD IDENTIFICATION BY SUHAS PATIL (S.K.)suhaspatil114
 
Computer aided drug designing
Computer aided drug designingComputer aided drug designing
Computer aided drug designingMuhammed sadiq
 
various approaches to drug discovery
various approaches to drug discoveryvarious approaches to drug discovery
various approaches to drug discoveryaiswarya thomas
 
Lead drug discovery
Lead drug discoveryLead drug discovery
Lead drug discoverysanchitbaba
 
Discovery on Target 2014 - The Industry's Preeminent Event on Novel Drug Targets
Discovery on Target 2014 - The Industry's Preeminent Event on Novel Drug TargetsDiscovery on Target 2014 - The Industry's Preeminent Event on Novel Drug Targets
Discovery on Target 2014 - The Industry's Preeminent Event on Novel Drug TargetsJaime Hodges
 
DRUG DESIGN BASED ON BIOINFORMATICS TOOLS
DRUG DESIGN BASED ON BIOINFORMATICS TOOLSDRUG DESIGN BASED ON BIOINFORMATICS TOOLS
DRUG DESIGN BASED ON BIOINFORMATICS TOOLSNIPER MOHALI
 

What's hot (20)

Drug discovery process powerpoint presentation slides ppt templates
Drug discovery process powerpoint presentation slides ppt templatesDrug discovery process powerpoint presentation slides ppt templates
Drug discovery process powerpoint presentation slides ppt templates
 
Drug design
Drug designDrug design
Drug design
 
Computer Aided Drug Design ppt
Computer Aided Drug Design pptComputer Aided Drug Design ppt
Computer Aided Drug Design ppt
 
Drug Discovery Process by Kashikant Yadav
Drug Discovery Process by Kashikant YadavDrug Discovery Process by Kashikant Yadav
Drug Discovery Process by Kashikant Yadav
 
Introduction To Drug Discovery
Introduction To Drug DiscoveryIntroduction To Drug Discovery
Introduction To Drug Discovery
 
Drug design, discovery and development
Drug design, discovery and developmentDrug design, discovery and development
Drug design, discovery and development
 
Drug discovery, Design & development basics
Drug discovery, Design & development basicsDrug discovery, Design & development basics
Drug discovery, Design & development basics
 
Drug Discovery Presentation
Drug Discovery PresentationDrug Discovery Presentation
Drug Discovery Presentation
 
Lead development and drug discovery
Lead development and drug discoveryLead development and drug discovery
Lead development and drug discovery
 
Basics of Drug Discovery and Development
Basics of Drug Discovery and DevelopmentBasics of Drug Discovery and Development
Basics of Drug Discovery and Development
 
Computer aided drug design(CADD)
Computer aided drug design(CADD)Computer aided drug design(CADD)
Computer aided drug design(CADD)
 
In silico methods in drug discovery and development
In silico methods in drug discovery and developmentIn silico methods in drug discovery and development
In silico methods in drug discovery and development
 
Development and sharing of ADME/Tox and Drug Discovery Machine learning models
Development and sharing of ADME/Tox and Drug Discovery Machine learning modelsDevelopment and sharing of ADME/Tox and Drug Discovery Machine learning models
Development and sharing of ADME/Tox and Drug Discovery Machine learning models
 
LEAD IDENTIFICATION BY SUHAS PATIL (S.K.)
LEAD IDENTIFICATION BY SUHAS PATIL (S.K.)LEAD IDENTIFICATION BY SUHAS PATIL (S.K.)
LEAD IDENTIFICATION BY SUHAS PATIL (S.K.)
 
Computer aided drug designing
Computer aided drug designingComputer aided drug designing
Computer aided drug designing
 
LEAD COMPOUNDS FROM NATURAL PRODUCT
LEAD COMPOUNDS FROM NATURAL PRODUCTLEAD COMPOUNDS FROM NATURAL PRODUCT
LEAD COMPOUNDS FROM NATURAL PRODUCT
 
various approaches to drug discovery
various approaches to drug discoveryvarious approaches to drug discovery
various approaches to drug discovery
 
Lead drug discovery
Lead drug discoveryLead drug discovery
Lead drug discovery
 
Discovery on Target 2014 - The Industry's Preeminent Event on Novel Drug Targets
Discovery on Target 2014 - The Industry's Preeminent Event on Novel Drug TargetsDiscovery on Target 2014 - The Industry's Preeminent Event on Novel Drug Targets
Discovery on Target 2014 - The Industry's Preeminent Event on Novel Drug Targets
 
DRUG DESIGN BASED ON BIOINFORMATICS TOOLS
DRUG DESIGN BASED ON BIOINFORMATICS TOOLSDRUG DESIGN BASED ON BIOINFORMATICS TOOLS
DRUG DESIGN BASED ON BIOINFORMATICS TOOLS
 

Viewers also liked

50 Most Creative CEO's to watch
50 Most Creative CEO's to watch50 Most Creative CEO's to watch
50 Most Creative CEO's to watchJulie Bryant
 
International Placements in Chemistry & "Kultur Brillen"
International Placements in Chemistry & "Kultur Brillen"International Placements in Chemistry & "Kultur Brillen"
International Placements in Chemistry & "Kultur Brillen"Ray Wallace
 
Information about Admission in NUST Engineering_2016
Information about Admission in NUST Engineering_2016Information about Admission in NUST Engineering_2016
Information about Admission in NUST Engineering_2016Atiqa khan
 
Drug Designing
Drug DesigningDrug Designing
Drug DesigningZainabSaif
 
Using Broadcast Media in Teaching: An example from the biosciences
Using Broadcast Media in Teaching: An example from the biosciencesUsing Broadcast Media in Teaching: An example from the biosciences
Using Broadcast Media in Teaching: An example from the biosciencesChris Willmott
 
Sequencing 2016
Sequencing 2016Sequencing 2016
Sequencing 2016Surya Saha
 
16_05-03_PR_Traverse Announces ARAD Award_FINAL
16_05-03_PR_Traverse Announces ARAD Award_FINAL16_05-03_PR_Traverse Announces ARAD Award_FINAL
16_05-03_PR_Traverse Announces ARAD Award_FINALJoseph Scaduto
 
Introducing the Biosciences eastern and central Africa–International Livestoc...
Introducing the Biosciences eastern and central Africa–International Livestoc...Introducing the Biosciences eastern and central Africa–International Livestoc...
Introducing the Biosciences eastern and central Africa–International Livestoc...ILRI
 

Viewers also liked (9)

50 Most Creative CEO's to watch
50 Most Creative CEO's to watch50 Most Creative CEO's to watch
50 Most Creative CEO's to watch
 
International Placements in Chemistry & "Kultur Brillen"
International Placements in Chemistry & "Kultur Brillen"International Placements in Chemistry & "Kultur Brillen"
International Placements in Chemistry & "Kultur Brillen"
 
Information about Admission in NUST Engineering_2016
Information about Admission in NUST Engineering_2016Information about Admission in NUST Engineering_2016
Information about Admission in NUST Engineering_2016
 
Drug Designing
Drug DesigningDrug Designing
Drug Designing
 
Using Broadcast Media in Teaching: An example from the biosciences
Using Broadcast Media in Teaching: An example from the biosciencesUsing Broadcast Media in Teaching: An example from the biosciences
Using Broadcast Media in Teaching: An example from the biosciences
 
Veterinary vaccine testing and approval
Veterinary vaccine testing and approvalVeterinary vaccine testing and approval
Veterinary vaccine testing and approval
 
Sequencing 2016
Sequencing 2016Sequencing 2016
Sequencing 2016
 
16_05-03_PR_Traverse Announces ARAD Award_FINAL
16_05-03_PR_Traverse Announces ARAD Award_FINAL16_05-03_PR_Traverse Announces ARAD Award_FINAL
16_05-03_PR_Traverse Announces ARAD Award_FINAL
 
Introducing the Biosciences eastern and central Africa–International Livestoc...
Introducing the Biosciences eastern and central Africa–International Livestoc...Introducing the Biosciences eastern and central Africa–International Livestoc...
Introducing the Biosciences eastern and central Africa–International Livestoc...
 

Similar to Stan Kahler CV 2016

Dynika CV-CCRP 07-Apr-15
Dynika CV-CCRP 07-Apr-15Dynika CV-CCRP 07-Apr-15
Dynika CV-CCRP 07-Apr-15Dynika St Omer
 
Tanweer Khan resume 121316
Tanweer Khan resume 121316Tanweer Khan resume 121316
Tanweer Khan resume 121316Tanweer khan
 
Resume 2013 sean ekins
Resume 2013 sean ekinsResume 2013 sean ekins
Resume 2013 sean ekinsSean Ekins
 
Semen quality and sperm dna damage ir relation to urinary bpa among men (Bisp...
Semen quality and sperm dna damage ir relation to urinary bpa among men (Bisp...Semen quality and sperm dna damage ir relation to urinary bpa among men (Bisp...
Semen quality and sperm dna damage ir relation to urinary bpa among men (Bisp...ricguer
 
Elisa Renee Swartz Resume April 2015
Elisa Renee Swartz Resume April 2015Elisa Renee Swartz Resume April 2015
Elisa Renee Swartz Resume April 2015Elisa Swartz
 
6 3-2016 regulatory affairs entry level resume bum kim
6 3-2016 regulatory affairs entry level resume bum kim6 3-2016 regulatory affairs entry level resume bum kim
6 3-2016 regulatory affairs entry level resume bum kimBum Kim
 
6-3-2016 Regulatory Affairs entry level resume_Bum Kim
6-3-2016 Regulatory Affairs entry level resume_Bum Kim6-3-2016 Regulatory Affairs entry level resume_Bum Kim
6-3-2016 Regulatory Affairs entry level resume_Bum KimBum Kim
 
Dr Viral Shah
Dr Viral Shah Dr Viral Shah
Dr Viral Shah drviral
 
38 experts on bpa panel consensus statement. effects in animals and potential...
38 experts on bpa panel consensus statement. effects in animals and potential...38 experts on bpa panel consensus statement. effects in animals and potential...
38 experts on bpa panel consensus statement. effects in animals and potential...ricguer
 
Deecher D Cv 3.5.09
Deecher D Cv 3.5.09Deecher D Cv 3.5.09
Deecher D Cv 3.5.09guest20d1ac
 
Russell RD CV April 2015
Russell RD CV April 2015Russell RD CV April 2015
Russell RD CV April 2015Ryan Russell
 
CURRICULUM VITAE
CURRICULUM  VITAECURRICULUM  VITAE
CURRICULUM VITAEAnuj Thakur
 
Eficacia de poractan vs beractan en sra metanalisis
Eficacia de poractan vs beractan en sra metanalisisEficacia de poractan vs beractan en sra metanalisis
Eficacia de poractan vs beractan en sra metanalisisMauricio Piñeros
 

Similar to Stan Kahler CV 2016 (20)

Dynika CV-CCRP 07-Apr-15
Dynika CV-CCRP 07-Apr-15Dynika CV-CCRP 07-Apr-15
Dynika CV-CCRP 07-Apr-15
 
Extreme makeover resume
Extreme makeover resumeExtreme makeover resume
Extreme makeover resume
 
Dr rahul-hajare cv-
Dr rahul-hajare cv-Dr rahul-hajare cv-
Dr rahul-hajare cv-
 
Tanweer Khan resume 121316
Tanweer Khan resume 121316Tanweer Khan resume 121316
Tanweer Khan resume 121316
 
Resume 2013 sean ekins
Resume 2013 sean ekinsResume 2013 sean ekins
Resume 2013 sean ekins
 
Semen quality and sperm dna damage ir relation to urinary bpa among men (Bisp...
Semen quality and sperm dna damage ir relation to urinary bpa among men (Bisp...Semen quality and sperm dna damage ir relation to urinary bpa among men (Bisp...
Semen quality and sperm dna damage ir relation to urinary bpa among men (Bisp...
 
Elisa Renee Swartz Resume April 2015
Elisa Renee Swartz Resume April 2015Elisa Renee Swartz Resume April 2015
Elisa Renee Swartz Resume April 2015
 
M koppe dixon-cv.2016
M koppe dixon-cv.2016M koppe dixon-cv.2016
M koppe dixon-cv.2016
 
6 3-2016 regulatory affairs entry level resume bum kim
6 3-2016 regulatory affairs entry level resume bum kim6 3-2016 regulatory affairs entry level resume bum kim
6 3-2016 regulatory affairs entry level resume bum kim
 
6-3-2016 Regulatory Affairs entry level resume_Bum Kim
6-3-2016 Regulatory Affairs entry level resume_Bum Kim6-3-2016 Regulatory Affairs entry level resume_Bum Kim
6-3-2016 Regulatory Affairs entry level resume_Bum Kim
 
Dr Viral Shah
Dr Viral Shah Dr Viral Shah
Dr Viral Shah
 
Application cv
Application cvApplication cv
Application cv
 
Application cv
Application cvApplication cv
Application cv
 
38 experts on bpa panel consensus statement. effects in animals and potential...
38 experts on bpa panel consensus statement. effects in animals and potential...38 experts on bpa panel consensus statement. effects in animals and potential...
38 experts on bpa panel consensus statement. effects in animals and potential...
 
Deecher D Cv 3.5.09
Deecher D Cv 3.5.09Deecher D Cv 3.5.09
Deecher D Cv 3.5.09
 
Russell RD CV April 2015
Russell RD CV April 2015Russell RD CV April 2015
Russell RD CV April 2015
 
Curriculum Vitae
Curriculum VitaeCurriculum Vitae
Curriculum Vitae
 
RESUME
RESUMERESUME
RESUME
 
CURRICULUM VITAE
CURRICULUM  VITAECURRICULUM  VITAE
CURRICULUM VITAE
 
Eficacia de poractan vs beractan en sra metanalisis
Eficacia de poractan vs beractan en sra metanalisisEficacia de poractan vs beractan en sra metanalisis
Eficacia de poractan vs beractan en sra metanalisis
 

Stan Kahler CV 2016

  • 1. CURRICULUM VITAE STANLEY B. KAHLER, B.A. Clinical Trials Management Resources, LLC 3585 Deer Valley Dr, Castle Rock, CO 80104 Phone 720-270-2309 email: sbkahler66@gmail.com Education Bachelor of Arts Union College Chemistry Lincoln, NE 1989 Experience Clinical Trials Management Resources, LLC 2009-present Clinical Research Coordinator Cedarburg Hauser Pharmaceuticals 2011-2012 Denver, CO Analytical Chemist Anlaytical Services Array Biopharma, Inc. 2006-2009 Longmont, CO Research Associate Analytical Research and Development Mayne Pharma 2005-2006 (formerly Napro Biotherapeutics, now Hospira) Boulder, CO Analytical Chemist Technical Services Group Tapestry Pharmaceuticals 2002-2005 (formerly Napro Biotherapeutics) Boulder, CO Chemist Analytical Development/Chemistry Development Napro Biotherapeutics 2000-2002 Boulder, CO Chemist Analytical Development/Chemistry Development Rosemont Pharmaceuticals 1993-2000 (now Upsher Smith) Analytical Chemist Harris Laboratories 1990-1992 Lincoln, NE Analytical Chemist
  • 2. Stanley B. Kahler, B.A. Page 2 of 3 Union College, Lincoln, NE 1985-1989 Full time student Investigative Trials Clinical Research Coordinator. A Phase 3, Multi-center, Randomized, Double-Blind, Controlled Study of the Long-Term Analgesic Efficacy and Safety of Tanezumab Alone or in Combination with Non-Steroidal Anti-inflammatory Drugs (NSAIDS ) versus NSAIDS Alone in Patients with Osteoarthritis of the Knee or Hip. Pfizer Inc. Jan 2009-May 2009. Clinical Research Coordinator. A 26 Week, Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of Single Intra-Articular Injection 1.2% Sodium Hyaluronate for Treatment of Painful Osteoarthritis of the Knee, with Optional 26-Week Open-Label Safety Extension. Ferring International Pharmascience Center, U.S., Inc. August 2009-April 2011. Clinical Research Coordinator. Long-term Allopurinol Safety Study Evaluating Outcomes in Gout Patients (LASSO). Ardea Biosciences, Inc. November 2011-May 2013. Clinical Research Coordinator. A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects with Gout who have had an Inadequate Hypouricemic Response to Standard of Care Allopurinol (CLEAR 1). Ardea Biosciences, Inc. March 2012-September 2014. Clinical Research Coordinator. A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Study to Assess the Efficacy and Safety of Lesinurad Monotherapy Compared to Placebo in Subjects with Gout who have had an Intolerance or Contraindication to a Xanthine Oxidase Inhibitor (LIGHT). Ardea Biosciences, Inc. March 2012- November 2013 Clinical Research Coordinator. A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Febuxostat Compared to Febuxostat Alone at Lowering Serum Uric Acid and Resolving Tophi in Subjects with Tophaceous Gout (CRYSTAL). Ardea Biosciences, Inc. March 2012-July 2014. Clinical Research Coordinator. A Long-Term Open-Label Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects with Gout. LIGHT Extension Study. Ardea Biosciences, Inc. November 2012-July 2014. Clinical Research Coordinator. A Long-Term Extension Study of Lesinurad in Combination with Allopurinol for Subjects Completing an Efficacy and Safety Study of Lesinurad and Allopurinol. CLEAR Extension Study. Ardea Biosciences, Inc. August 2013-present. Clinical Research Coordinator. A Long-Term Extension Study of Lesinurad in Combination with Febuxostat for Subjects with Gout Completing an Efficacy and Safety Study of Lesinurad and Febuxostat. CRYSTAL Extension Study. Ardea Biosciences, Inc. May 2013-present.
  • 3. Stanley B. Kahler, B.A. Page 3 of 3 Clinical Research Coordinator. A Multi-Center, Randomized, Double-Blind, Phosphate Buffered Saline-Controlled Study to Evaluate Effectiveness and Safety of a Single Intra-Articular Injection of Gel-One® for the Treatment of Osteoarthritis of the Knee with Open-Label Safety Extension. August 2013 - April 2016 Clinical Research Coordinator. A Study to Determine the Presence and Volume of Monosodium Urate Crystals as Assessed by Dual-Energy Computed Tomography in Gout Patients Treated with Allopurinol. May 2015 – March 2016